3-[7-(2-Hydroxy-2-methylpropyl)-8-oxo-9-(tetrahydro-2H-pyran-4-yl)-8,9-dihydro-7H-purin-2-yl]imidazo[1,2-a]pyridine-6-carbonitrile

ID: ALA4536380

PubChem CID: 54766428

Max Phase: Preclinical

Molecular Formula: C22H23N7O3

Molecular Weight: 433.47

Molecule Type: Unknown

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  CC(C)(O)Cn1c(=O)n(C2CCOCC2)c2nc(-c3cnc4ccc(C#N)cn34)ncc21

Standard InChI:  InChI=1S/C22H23N7O3/c1-22(2,31)13-28-17-11-25-19(16-10-24-18-4-3-14(9-23)12-27(16)18)26-20(17)29(21(28)30)15-5-7-32-8-6-15/h3-4,10-12,15,31H,5-8,13H2,1-2H3

Standard InChI Key:  GVFYFXFHOOSHAM-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 32 36  0  0  0  0  0  0  0  0999 V2000
    7.4331  -28.3169    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1918  -26.3028    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1907  -27.1223    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.8987  -27.5313    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.8970  -25.8939    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.6056  -26.2992    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.6058  -27.1178    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.3845  -27.3706    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.8655  -26.7081    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.3841  -26.0460    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.4885  -25.8947    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1950  -25.6201    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.7421  -26.2272    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6035  -24.9123    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4060  -25.0849    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.9537  -24.4797    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7044  -23.6983    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9019  -23.5256    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3488  -24.1343    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.6396  -25.2724    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.4402  -25.1039    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.3485  -23.8889    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.0920  -24.6676    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.1486  -23.7223    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    7.6929  -24.3318    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.6827  -26.7078    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.6372  -28.1477    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.9800  -27.7097    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.6856  -29.0941    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    8.2214  -28.5274    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2537  -23.0908    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.8029  -22.4857    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  2  3  2  0
  3  4  1  0
  4  7  2  0
  6  5  2  0
  5  2  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10  6  1  0
 11 15  1  0
 14 12  2  0
 12 13  1  0
 13 11  2  0
  2 11  1  0
 14 15  1  0
 14 19  1  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 20 21  1  0
 20 23  1  0
 21 25  1  0
 22 23  1  0
 10 20  1  0
 22 24  1  0
 24 25  1  0
  9 26  2  0
  8 27  1  0
 27  1  1  0
  1 28  1  0
  1 29  1  0
  1 30  1  0
 31 32  3  0
 17 31  1  0
M  END

Associated Targets(Human)

JAK3 Tclin Tyrosine-protein kinase JAK3 (8349 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
JAK2 Tclin Tyrosine-protein kinase JAK2 (12915 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
JAK1 Tclin Tyrosine-protein kinase JAK1 (8569 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 433.47Molecular Weight (Monoisotopic): 433.1862AlogP: 1.90#Rotatable Bonds: 4
Polar Surface Area: 123.26Molecular Species: NEUTRALHBA: 10HBD: 1
#RO5 Violations: HBA (Lipinski): 10HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 4.53CX LogP: 1.29CX LogD: 1.29
Aromatic Rings: 4Heavy Atoms: 32QED Weighted: 0.52Np Likeness Score: -1.24

References

1. Bach J, Eastwood P, González J, Gómez E, Alonso JA, Fonquerna S, Lozoya E, Orellana A, Maldonado M, Calaf E, Albertí J, Pérez J, Andrés A, Prats N, Carreño C, Calama E, De Alba J, Calbet M, Miralpeix M, Ramis I..  (2019)  Identification of 2-Imidazopyridine and 2-Aminopyridone Purinones as Potent Pan-Janus Kinase (JAK) Inhibitors for the Inhaled Treatment of Respiratory Diseases.,  62  (20): [PMID:31609613] [10.1021/acs.jmedchem.9b00533]

Source